BioXmark® liquid fiducials to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial

BACKGROUND AND PURPOSE: Dose-escalation in rectal cancer (RCa) may result in an increased complete response rate and thereby enable omission of surgery and organ preservation. In order to implement dose-escalation, it is crucial to develop a technique that allows for accurate image-guided radiothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Opbroek, Thirza J.S., Willems, Yves C.P., Verhaegen, Frank, de Ridder, Rogier, Hoge, Chantal, Melenhorst, Jarno, Bakers, Frans, Grabsch, Heike I., Buijsen, Jeroen, Van Limbergen, Evert J., Canters, Richard A.M., Berbée, Maaike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668658/
https://www.ncbi.nlm.nih.gov/pubmed/36407490
http://dx.doi.org/10.1016/j.ctro.2022.10.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668658/
https://www.ncbi.nlm.nih.gov/pubmed/36407490
http://dx.doi.org/10.1016/j.ctro.2022.10.013

Ejemplares similares